This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Biological E Limited. Active years: 2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019
Title: **Ravi Pratap Narayan Mishra: Innovator in Biopharmaceuticals**
Introduction
Ravi Pratap Narayan Mishra, based in Hyderabad, Telangana, India, is a dedicated inventor with a focus on biotechnology and pharmaceutical advancements. He has made significant contributions to the field with a patent that has the potential to enhance the production of vital proteins used in medical applications.
Latest Patents
Mishra holds a notable patent titled "Codon optimized polynucleotide for high level expression of CRM197." This invention addresses the challenge of achieving high levels of bacterial toxoid or toxin protein expression. By employing an optimized novel polynucleotide sequence and transforming suitable host cells, the invention enables the efficient production and isolation of polypeptide CRM197. This breakthrough method not only enhances protein expression but also streamlines the purification process, facilitating advancements in therapeutic applications.
Career Highlights
Ravi Pratap Narayan Mishra is associated with Biological E Limited, a prominent biopharmaceutical company known for its innovations in vaccine and biologics production. His work at the company highlights his commitment to improving health outcomes through scientific innovation.
Collaborations
Throughout his career, Mishra has collaborated with distinguished coworkers, including Akshay Goel and Narender Dev Mantena. These collaborations contribute to a dynamic research environment that fosters innovative solutions in biopharmaceuticals.
Conclusion
Ravi Pratap Narayan Mishra stands out as an influential inventor in the biopharmaceutical sector. His patent on optimized polynucleotide sequences showcases his innovative spirit and dedication to advancing medical biotechnology. As he continues his work at Biological E Limited, Mishra is poised to make further contributions that may positively impact healthcare and therapeutic protein production.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
